| scholarly article | Q13442814 |
| P2093 | author name string | Yang Li | |
| Wei Guo | |||
| He-Wei Jiang | |||
| Shu-Juan Guo | |||
| Sheng-Ce Tao | |||
| He-Cheng Li | |||
| Cheng-Qiang Li | |||
| P2860 | cites work | P53 autoantibodies in 1006 patients followed up for breast cancer | Q24791426 |
| Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients | Q26772945 | ||
| Natural antibodies bridge innate and adaptive immunity | Q26829636 | ||
| Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer | Q27002356 | ||
| Lessons learned from twins in autoimmune and chronic inflammatory diseases | Q29994578 | ||
| A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1 | Q30830656 | ||
| DAnTE: a statistical tool for quantitative analysis of -omics data. | Q31154320 | ||
| Autoantibody signatures in prostate cancer | Q33223730 | ||
| Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical course | Q33230009 | ||
| Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers | Q33443439 | ||
| Detection and monitoring of serum p53 antibodies in patients with colorectal cancer | Q33617886 | ||
| p53 Antibodies in the sera of patients with various types of cancer: a review | Q33892337 | ||
| Tumor-associated autoantibodies as diagnostic and prognostic biomarkers | Q34049184 | ||
| Clinical validation of an autoantibody test for lung cancer | Q34537374 | ||
| B-cell repertoire responses to varicella-zoster vaccination in human identical twins | Q34985620 | ||
| The autoantibody repertoire: searching for order | Q35038302 | ||
| Autoantibody signatures: progress and perspectives for early cancer detection | Q35377236 | ||
| Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics | Q35649417 | ||
| Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy | Q35849866 | ||
| Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review). | Q35934485 | ||
| Systematic identification of arsenic-binding proteins reveals that hexokinase-2 is inhibited by arsenic. | Q36371410 | ||
| Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray | Q36539497 | ||
| Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. | Q36927352 | ||
| Lineage structure of the human antibody repertoire in response to influenza vaccination | Q36975946 | ||
| Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling | Q37415666 | ||
| In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway | Q37474087 | ||
| Autoantibodies: Opportunities for Early Cancer Detection | Q38656064 | ||
| Deciphering the complexity of the cancer proteome for diagnostic applications. | Q38676337 | ||
| Antigen arrays for profiling autoantibody repertoires | Q38812946 | ||
| Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment. | Q39468956 | ||
| Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer | Q40414975 | ||
| AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies | Q41819064 | ||
| Intracellular tumor-associated antigens represent effective targets for passive immunotherapy. | Q45876979 | ||
| Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens | Q46646453 | ||
| Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. | Q46821034 | ||
| Identification of Serological Biomarkers for Early Diagnosis of Lung Cancer Using a Protein Array-Based Approach | Q47142485 | ||
| Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy. | Q47831533 | ||
| Comparative Analysis of Gene Expression Profiles Involved in Calcium Signaling Pathways Using the NLVH Animal Model of Schizophrenia | Q47928836 | ||
| Negative conversion of high serum p53 antibody titers in a patient with gastric cancer at 31 months after surgery | Q48104948 | ||
| Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality | Q49419816 | ||
| Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer. | Q52328709 | ||
| A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors. | Q52594384 | ||
| New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms. | Q52641617 | ||
| Cancer: Antibodies regulate antitumour immunity. | Q53524931 | ||
| Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer | Q56965679 | ||
| GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis | Q59791283 | ||
| Serum p53 antibodies as early markers of lung cancer | Q71803498 | ||
| Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events | Q73032215 | ||
| Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy | Q79318066 | ||
| Immune response as a biomarker for cancer detection and a lot more | Q81246153 | ||
| Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG | Q91045967 | ||
| Natural antibodies - facts known and unknown | Q91871967 | ||
| Individual and stable autoantibody repertoires in healthy individuals | Q92139454 | ||
| Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors | Q93051756 | ||
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 102674 | |
| P577 | publication date | 2020-02-26 | |
| P1433 | published in | EBioMedicine | Q24912341 |
| P1476 | title | Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma | |
| P478 | volume | 53 |
| Q97523390 | SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses | cites work | P2860 |
Search more.